Publication date: Jul 20, 2024
Uptake of the COVID-19 vaccine among pregnant persons is lower than the general population. This scoping review explored pregnant people’s attitudes towards the COVID-19 vaccine, reasons for vaccine hesitancy, and whether attitudes about COVID-19 vaccines differ by country of origin. A scoping review was conducted across PubMed, Embase, CINHAL, and Scopus. Inclusion criteria were articles published in English from 2019-2022 focused on attitudes towards COVID-19 vaccination among pregnant persons. Data analysis was done via the 5Cs framework for vaccine hesitancy: Constraints, Complacency, Calculation, Confidence, and Collective Responsibility. 44 articles were extracted. A lack of confidence in vaccine safety was the most prevalent theme of hesitancy among pregnant persons. This was largely driven by a lack of access to information about the vaccine as well as mistrust of the vaccine and medical professionals. Meanwhile, vaccine acceptance was mostly driven by a desire to protect themselves and their loved ones. Overall, COVID-19 vaccine hesitancy among pregnant persons continues to be high. Vaccine hesitancy is primarily driven by fear of the unknown side effects of the vaccine on pregnant persons and their fetuses along with a lack of information and medical mistrust. Some differences can be seen between high income and low- and middle-income countries regarding vaccine hesitancy, showing that a single solution cannot be applied to all who are vaccine hesitant. General strategies, however, can be utilized to reduce vaccine hesitancy, including advocating for inclusion of pregnant persons in clinical trials and incorporating consistent COVID-19 vaccine counseling during prenatal appointments.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Global | Attitudes |
| Mistrust | Confidence |
| Pregnant | Covid |
| Vaccination | Driven |
| General | |
| Hesitancy | |
| High | |
| Inclusion | |
| Income | |
| Mistrust | |
| Persons | |
| Pregnant | |
| Scoping | |
| Vaccine | |
| Vaccines |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | VO | COVID-19 vaccine |
| disease | VO | population |
| disease | VO | vaccine |
| disease | MESH | COVID-19 |
| disease | IDO | country |
| disease | VO | vaccination |
| disease | VO | LACK |
| disease | VO | USA |
| drug | DRUGBANK | Silver |
| disease | MESH | Rare Diseases |
| disease | MESH | influenza |
| disease | MESH | measles |
| pathway | KEGG | Measles |
| disease | MESH | mumps |
| disease | MESH | rubella |
| disease | VO | vaccine dose |
| disease | IDO | production |
| disease | MESH | complications |
| disease | MESH | death |
| disease | MESH | chronic conditions |
| disease | MESH | infection |
| disease | IDO | process |
| disease | VO | vaccinated |
| disease | MESH | visual impairments |
| disease | MESH | preterm birth |
| disease | VO | unvaccinated |
| disease | VO | Canada |
| drug | DRUGBANK | Methyl isocyanate |
| drug | DRUGBANK | Troleandomycin |
| disease | VO | effectiveness |
| disease | VO | pregnant women |
| disease | MESH | re infection |
| disease | MESH | infertility |
| drug | DRUGBANK | Aspartame |
| disease | MESH | vaccine preventable diseases |
| drug | DRUGBANK | Coenzyme M |
| disease | VO | organ |
| disease | VO | immunization |
| disease | IDO | intervention |
| disease | VO | effective |